Filter
422
Filtered Results: 422
Text search:
seroprevalence
survey
Featured
Recommendations
27
New Publications
133
Language
Document type
No document type
252
Guidelines
60
Studies & Reports
57
Strategic & Response Plan
16
Manuals
15
Fact sheets
14
Situation Updates
5
Resource Platforms
2
Training Material
1
Countries / Regions
Nigeria
23
Global
16
Sierra Leone
13
Congo, Democratic Republic of
13
India
11
Benin
9
Senegal
9
Latin America and the Carribbean
9
South Africa
9
Tanzania
8
Lesotho
7
Cameroon
7
Africa
7
Western and Central Europe
7
Central African Republic
7
Cambodia
6
Asia
6
Middle East and North Africa
6
Brazil
6
Nepal
5
Rwanda
5
Burkina Faso
5
Uganda
5
Eastern Europe
5
Ukraine
4
Syria
4
West and Central Africa
4
Russia
4
Yemen
4
Zambia
4
Liberia
4
Myanmar / Burma
4
Pakistan
4
Zimbabwe
3
Haiti
3
South–East Asia Region
3
East and Southern Africa
3
Namibia
3
Ethiopia
3
Indonesia
3
Madagascar
3
Colombia
2
Kenya
2
Turkey
2
Ghana
2
Afghanistan
2
Malawi
2
Philippines
2
Guinea
2
Mozambique
2
Germany
2
Bangladesh
2
Vietnam
2
Moldova
2
Somalia
2
Guatemala
2
North Macedonia
1
Chile
1
Iran
1
Albania
1
Niger
1
Peru
1
Qatar
1
Armenia
1
USA
1
Venezuela
1
Jordan
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
North America
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Southern Africa
1
Bolivia
1
Argentina
1
Lebanon
1
Djibouti
1
Egypt
1
Sudan
1
Palestine
1
Honduras
1
Libya
1
Botswana
1
South Sudan
1
Iraq
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
189
Clinical Guidelines
23
Public Health
12
Key Resources
6
Pharmacy & Technologies
5
Capacity Building
1
Women & Child Health
1
Toolboxes
HIV
60
COVID-19
57
NTDs
35
TB
33
Rapid Response
22
Ebola & Marburg
12
Zika
11
Mental Health
7
Planetary Health
6
Polio
5
Refugee
4
Disability
3
Natural Hazards
1
Cholera
1
Caregiver
1
Conflict
1
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
Regional Operational Plan 2016 FY17 Strategic Direction Summary
2 May 2016
Editorial Review
AIDS 2019, 33:1411–1420
The WHO Guide on Oral Cholera Vaccines in Mass Immunization Campaigns provides guidance on the planning and implementation of oral cholera vaccine (OCV) campaigns. It covers key aspects such as when and where to use OCVs, vaccine specifications, and recommendations for use in endemic areas, outbreak...
Working towards better COVID-19 outcomes in the WHO European Region.From the first COVID-19 cases in Europe reported on
24 January 2020, the pandemic reached 1 million cases
within 3 months, 10 million cases within 8 months, and
100 million cases in Europe alone within 2 years. Over
the course o...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Technical Paper
The goal of the United States Government for the President's Emergency Plan for AIDS Relief (PEPFAR) in Mozambique is to support country efforts to achieve epidemic control by 2020 through evidence-based policies and interventions to drive progress and save
lives. This document details PEPFAR's op...
BMC Infectious Diseases (2024) 24:1102
Communities living along the shoreline and on the islands of Lake Victoria in northwestern Tanzania
remain endemic for schistosomiasis and suffer from the life-threatening morbidities associated with the disease.
